Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy Peter F. MuldersMaria De SantisKarim Fizazi Review Open access 30 May 2015 Pages: 655 - 663
Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia Carlos Cuesta-MateosJavier LoscertalesCecilia Muñoz-Calleja Original Article 28 February 2015 Pages: 665 - 676
CEA/CD3-bispecific T cell-engaging (BiTE) antibody-mediated T lymphocyte cytotoxicity maximized by inhibition of both PD1 and PD-L1 Takuya OsadaSandip P. PatelH. Kim Lyerly Original Article 06 March 2015 Pages: 677 - 688
Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer Sean G. SmithBhanu prasanth KoppoluDavid A. Zaharoff Original Article 10 March 2015 Pages: 689 - 696
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma Takumi KumaiToshihiro NagatoYasuaki Harabuchi Original Article 10 March 2015 Pages: 697 - 705
Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response Naoya HashimotoAkihiro TsuboiHaruo Sugiyama Original Article 14 March 2015 Pages: 707 - 716
Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cells José Medina-EcheverzMarcos VasquezPedro Berraondo Original Article 21 March 2015 Pages: 717 - 725
Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma Laura K. AguilarLawrence A. ShirleyMark Bloomston Original Article 21 March 2015 Pages: 727 - 736
Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists RuiKun ZhongHongying LiEdward D. Ball Original Article 21 March 2015 Pages: 737 - 744
FoxP3+ and IL-17+ cells are correlated with improved prognosis in cervical adenocarcinoma Simone PuntMarjolein E. van VlietEkaterina S. Jordanova Original Article Open access 21 March 2015 Pages: 745 - 753
Impairment of lymphocyte function following yttrium-90 DOTATOC therapy Vahé BarsegianChristian HuebenMonika Lindemann Original Article 31 March 2015 Pages: 755 - 764
Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report Juan Martin-LiberalAndrew JS FurnessJames Larkin Original Article 01 April 2015 Pages: 765 - 767
Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial Lina PrasmickaiteGisle BergeGunhild M. Mælandsmo Original Article 02 April 2015 Pages: 769 - 776
Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model Nana ChenNaomi NishioKen-ichi Isobe Original Article 02 April 2015 Pages: 777 - 789
